Post Study Continuation of C7 for G1D
Post Study Continuation of C7 for G1D
This protocol provides ongoing access to triheptanoin for patients who did complete an initial pilot protocol, and provides the opportunity to collect long-term safety data from patients treated with triheptanoin.
Only patients who completed the initial pilot study were eligible. The study is ongoing with these patients only.
Inclusion Criteria:
Exclusion Criteria: